跳至主要内容
临床试验/ITMCTR2200006443
ITMCTR2200006443尚未招募未知

Exploring the therapeutic mechanism of Batuanjin in the treatment of elderly stable angina pectoris based on gut microbiota - lipid metabolism spectrum

Guang'anmen Hospital of Chinese Academy of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
60 至 80(—)
性别
All

入选标准

  • (1) meet the diagnostic criteria of stable angina pectoris published by Chinese Medical Association in 2018 guidelines for diagnosis and treatment of chronic stable angina Pectoris.
  • (2) between 60 and 80 years old.
  • (3) patients with severe angina pectoris classified as I~III by Canadian Cardiovascular Association (CCS).
  • (4) those who sign the informed consent form. Those who have the above four items at the same time are included in the scope of the test.

排除标准

  • (1) severe arrhythmia and moderate cardiac insufficiency (EF < 40%) (2) Hypertension is more than 180/100mmHg (3) patients with AMI history or percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), severe trauma and cerebrovascular accident in recent 3 months. (4) patients with severe shock and severe primary organ diseases such as liver, kidney and lung. (5) patients with obvious infection, fever and severe anemia. (6) severe joint disease, which is not suitable for those who exercise eight-paragraph jingle. (7) use antibiotics or participate in any probiotics or laxatives research in the 3 months prior to the study.(8) There were no gastrointestinal diseases such as diarrhea and ulcerative colitis in the past two months.

研究者

发起方
Guang'anmen Hospital of Chinese Academy of traditional Chinese Medicine

相似试验

Exploring the therapeutic mechanism of Batuanjin in... | 临床试验